Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
基本信息
- 批准号:7939375
- 负责人:
- 金额:$ 5.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-28 至 2010-09-27
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntisense OligonucleotidesApoptosisBreast Cancer CellBreast Cancer TreatmentCell LineCellsCharacteristicsDNADimensionsERBB2 geneElectronsEstrogen receptor positiveEvaluationFluorescenceFundingGene ExpressionGene TargetingGenesGoalsHigh Pressure Liquid ChromatographyHybridsInvestigationKnowledgeLiquid substanceMCF7 cellMammary NeoplasmsMeasurementMeasuresMetabolismMethenamineMicroscopicMitotic Cell CycleMolecularMorphologyOligonucleotidesPhysical condensationPolyaminesProgress ReportsProteinsRadioactiveRegulationRoleScanningSpecificitySpectrum AnalysisSpermineStructureTechniquesTemperatureTestingTransgenic AnimalsTransgenic MiceTumor Tissueanalogbasec-myc Genescancer cellcancer therapycell growthdesigngene therapyin vivolight scatteringmalignant breast neoplasmmeltingmouse modelnanoparticlenovelnovel strategiesoverexpressionphosphodiesterphosphorothioateplasmid DNAuptake
项目摘要
DESCRIPTION (provided by applicant): The overall goal of this project is to elucidate the mechanism of action of polyamine analogues in facilitating the uptake and function of antisense oligonucleotides (ODNs). The hypothesis is that the selectivity of polyamine analogues in DNA condensation and/or stabilization of RNA.DNA hybrids can be utilized to facilitate the cellular uptake and function antisense ODNs for breast cancer therapy. Antisense ODNs targeted to c-myc and HER-2 genes will be studied. To evaluate the structural specificity effects of polyamine analogues on RNA.DNA hybrid stabilization, association constants will be determined using a molecular beacon technique. The role of ODN nanoparticles in facilitating cellular uptake of ODNs will be quantified by dynamic light scattering as well as electron, scanning force and polarizing spectroscopy. Cellular uptake and function of ODNs will be measured using MCF-7 and SK-BR-3 breast cancer cells. ODN uptake will be determined using radioactive and fluorescent ODNs. Effects of polyamine analogue/ODN combinations on target gene expression, cell growth arrest, and apoptosis will be examined to demonstrate enhanced function of ODNs. Subsequently, HER-2 gene targeted ODN and selected polyamine analogues will be examined for in vivo ODN delivery and function using a transgenic mouse model of breast cancer. The effects of polyamine analogues and ODNs on natural polyamines will be quantified by HPLC. These studies will advance our knowledge of the mechanism of cellular uptake of ODNs, and help to develop novel approaches for breast cancer therapy.
描述(由申请人提供):本项目的总体目标是阐明多胺类似物在促进反义寡核苷酸(ODN)摄取和功能方面的作用机制。假设多胺类似物在DNA缩合和/或RNA稳定中的选择性,DNA杂合体可用于促进细胞摄取和功能反义ODNs用于乳腺癌治疗。针对c-myc和HER-2基因的反义ODNs将被研究。为了评价多胺类似物对RNA、DNA杂交稳定性的结构特异性影响,将使用分子信标技术测定缔合常数。ODN纳米颗粒在促进细胞摄取ODN中的作用将通过动态光散射以及电子、扫描力和偏振光谱来量化。将使用MCF-7和SK-BR-3乳腺癌细胞测量ODN的细胞摄取和功能。将使用放射性和荧光ODN测定ODN摄取。将检查多胺类似物/ODN组合对靶基因表达、细胞生长停滞和凋亡的影响,以证明ODN的增强功能。随后,HER-2基因靶向的ODN和选择的多胺类似物将使用乳腺癌的转基因小鼠模型检查体内ODN递送和功能。多胺类似物和ODN对天然多胺的影响将通过HPLC定量。这些研究将促进我们对ODNs细胞摄取机制的认识,并有助于开发乳腺癌治疗的新方法。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Biogenic and synthetic polyamines bind bovine serum albumin.
- DOI:10.1021/bm100144v
- 发表时间:2010-06-14
- 期刊:
- 影响因子:6.2
- 作者:Dubeau, S.;Bourassa, P.;Thomas, T. J.;Tajmir-Riahi, H. A.
- 通讯作者:Tajmir-Riahi, H. A.
Lithium ion induced stabilization of the liquid crystalline DNA.
锂离子诱导液晶 DNA 的稳定。
- DOI:10.1002/mabi.200500145
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Sundaresan,Neethu;Thomas,Thresia;Thomas,ThekkumkatJohn;Pillai,ChennakkattuKrishnaSadasivan;Pillai,ChennakkatuKrishnaSaolashiuan
- 通讯作者:Pillai,ChennakkatuKrishnaSaolashiuan
Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes.
- DOI:10.1021/nn901796n
- 发表时间:2010-07-27
- 期刊:
- 影响因子:17.1
- 作者:Chen, Alex M.;Taratula, Oleh;Wei, Dongguang;Yen, Hsin-I;Thomas, Thresia;Thomas, T. J.;Minko, Tamara;He, Huixin
- 通讯作者:He, Huixin
Liquid crystalline phase behavior of high molecular weight DNA: a comparative study of the influence of metal ions of different size, charge and binding mode.
- DOI:10.1021/bm800101x
- 发表时间:2008-05
- 期刊:
- 影响因子:6.2
- 作者:N. Sundaresan;C. Suresh;T. Thomas;T. Thomas;C. Pillai
- 通讯作者:N. Sundaresan;C. Suresh;T. Thomas;T. Thomas;C. Pillai
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TJ THOMAS其他文献
TJ THOMAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TJ THOMAS', 18)}}的其他基金
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6633220 - 财政年份:2000
- 资助金额:
$ 5.75万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6376346 - 财政年份:2000
- 资助金额:
$ 5.75万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6748436 - 财政年份:2000
- 资助金额:
$ 5.75万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6443430 - 财政年份:2000
- 资助金额:
$ 5.75万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6449297 - 财政年份:2000
- 资助金额:
$ 5.75万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6513053 - 财政年份:2000
- 资助金额:
$ 5.75万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6200101 - 财政年份:2000
- 资助金额:
$ 5.75万 - 项目类别:
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
- 批准号:
6630988 - 财政年份:1999
- 资助金额:
$ 5.75万 - 项目类别:
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
- 批准号:
6889575 - 财政年份:1999
- 资助金额:
$ 5.75万 - 项目类别:
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
- 批准号:
7034171 - 财政年份:1999
- 资助金额:
$ 5.75万 - 项目类别:
相似海外基金
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
- 批准号:
10759950 - 财政年份:2023
- 资助金额:
$ 5.75万 - 项目类别:
Inducing H3F3A exon skipping with antisense oligonucleotides as an approach to treat diffuse intrinsic pontine glioma
用反义寡核苷酸诱导 H3F3A 外显子跳跃作为治疗弥漫性内源性脑桥胶质瘤的方法
- 批准号:
10677284 - 财政年份:2023
- 资助金额:
$ 5.75万 - 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
- 批准号:
10464020 - 财政年份:2022
- 资助金额:
$ 5.75万 - 项目类别:
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
使用反义寡核苷酸促进成人海马神经发生作为阿尔茨海默氏病的治疗
- 批准号:
10484703 - 财政年份:2022
- 资助金额:
$ 5.75万 - 项目类别:
Strategy for specific delivery of antisense oligonucleotides to T cells
将反义寡核苷酸特异性递送至 T 细胞的策略
- 批准号:
10547347 - 财政年份:2022
- 资助金额:
$ 5.75万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10806783 - 财政年份:2022
- 资助金额:
$ 5.75万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10689248 - 财政年份:2022
- 资助金额:
$ 5.75万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10501862 - 财政年份:2022
- 资助金额:
$ 5.75万 - 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
- 批准号:
10623180 - 财政年份:2022
- 资助金额:
$ 5.75万 - 项目类别:
Identifying binding partners, biological substrates and antisense oligonucleotides regulating expression of short and long ACE2.
识别调节短和长 ACE2 表达的结合伴侣、生物底物和反义寡核苷酸。
- 批准号:
BB/V019848/1 - 财政年份:2021
- 资助金额:
$ 5.75万 - 项目类别:
Research Grant